Dexmedetomidine Versus Midazolam for End-of-Life Sedation and Agitation: Protocol for a Randomized Controlled Trial (The DREAMS Trial).

Benjamin ThomasGreg BarclayWing-Shan Angela LoJudy MullanKylie J Mansfield
Published in: JMIR research protocols (2024)
DERR1-10.2196/55129.